Erythropoietin use in critically ill patients: forest and trees

Corwin, Howard L.
September 2007
CMAJ: Canadian Medical Association Journal;9/25/2007, Vol. 177 Issue 7, p747
Academic Journal
The article presents the author's views on the role of erythropoientin in severely ill patients. The author says that circulation of erythropoietin concentrations stop in patients with anemia which results in low hemoglobin. The haemoglobin concentration is increased in critically ill patients through stimulation of erythropoietin. A study confirmed that erythropoietin decreases mortality among trauma patients who are admitted to the intensive care units for more than 48 hours.


Related Articles

  • Dosage of Erythropoietin and iron-replacement therapy in patients on chronic hemodialysis. Ostrvica, Edin; Ostrvica, Dzenana; Katica, Vahidin // HealthMed;Mar2010, Vol. 4 Issue 1, p138 

    Anemias are diseases of decreased number of erythrocytes or hemoglobin in a volume blood unit with hypoxia of muscles as a result. The objective of the study was to establish iron-replacement therapies to achieve target values of hemoglobin and hematocrit in renal anemia treatmnet by...

  • Managing anemia in dialysis patients: hemoglobin cycling and overshoot. Singh, Ajay K.; Milford, Edgar; Fishbane, Steven; Keithi-Reddy, Sai Ram // Kidney International;Sep2008, Vol. 74 Issue 5, p679 

    The article presents a discussion on management of anemia in dialysis patients. It mentions that anemia is present in most of patients on dialysis and presents a combination of erythropoietin deficiency and iron deficiency, as well as bone marrow resistance to erythropoietin. The management of...

  • Impact of an Anemia Clinic on Emergency Room Visits and Hospitalizations in Patients with Anemia of CKD Pre-Dialysis. Perkins, Robert; Olson, Stephen; Hansen, Janice; Lee, Joseph; Stiles, Kevin; Lebrun, Christopher // Nephrology Nursing Journal;Mar/Apr2007, Vol. 34 Issue 2, p167 

    Aim. There is limited data regarding the impact on hospital resource use of a dedicated, nurse-managed anemia clinic in patients with pre-end stage chronic kidney disease. Methods. A retrospective cohort study was conducted comparing patients with pre-end stage anemia of chronic kidney disease...

  • Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Duman, Neval; Uyanik, Abdullah; Unsal, Abdulkadir; Sezer, Siren; Camsari, Taner; Cirit, Mustafa; Yilmaz, Mehmet Emin; Altun, Bülent; Duranay, Murat; Yildiz, Alaattin; Sahin, Idris; Dogukan, Ayhan; Ustundag, Sedat; Karayaylali, Ibrahim; Kahveci, Arzu; Sindel, Sukru; Kiykim, Ahmet Alper; Yenicerioglu, Yavuz; Akbas, Ertugrul; Ozdener, Fatih // Clinical Kidney Journal;Oct2014, Vol. 7 Issue 5, p464 

    Background This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey....

  • Erythropoietins in cancer patients: ESMO Recommendations for use. Greil, R.; Thödtmann, R. // Annals of Oncology;May2007 Supplement 2, Vol. 18, pii86 

    The article presents clinical recommendations from the European Society for Medical Oncology (ESMO) for use of erythropoietins in cancer patients. Anaemia in cancer refers to a decrease in haemoglobin (Hb) level below normal lower limit. Chronic anaemia is usually present in 40% of cancer...

  • Serum Erythropoietin Levels in Pediatric Hematologic Disorders and Impact of Recombinant Human Erythropoietin Use. Çetin, Mualla; Ünal, Şule; Gümrük, Fatma; Gürgey, Aytemiz; Altay, Çiğdem // Turkish Journal of Hematology;Jun2009, Vol. 26 Issue 2, p72 

    Objective: In anemic patients, the correlation between serum erythropoietin (sEpo) level and the severity of anemia has been reported previously. However, in different anemia groups, different sEpo levels are measured in patients with similar hemoglobin levels and the etiology of this situation...

  • Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Ferruh Artunc; Teut Risler // Nephrology Dialysis Transplantation;Oct2007, Vol. 22 Issue 10, p2900 

    Background. Renal anaemia is caused by a relative erythropoietin (EPO) deficiency. Due to difficult interpretation of serum EPO concentrations adapted to anaemia and renal function, the diagnostic value of measuring serum EPO concentrations is limited. Methods. We retrospectively analysed the...

  • Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis. Taylor, J.; Mactier, R.A.; Stewart, W.K.; Henderson, I.S. // BMJ: British Medical Journal (International Edition);9/8/90, Vol. 301 Issue 6750, p476 

    Presents case reports on effect the erythropoietin on anemia in patients with myeloma receiving hemodialysis in Great Britain. Use of erythropoietin on the two patients; Reaction of erythropoietin marrow cells on the drug; Response of the patients on erythropoietin.

  • Effects of withdrawing erythropoietin. Tierney, A.J.; Leonard, R.C.F.; Taylor, J.; Closs, S.J.; Chetty, U.; Rodger, A. // BMJ: British Medical Journal (International Edition);2/2/91, Vol. 302 Issue 6771, p272 

    Studies the effects of withdrawing erythropoietin in the treatment of anemia in chronic renal failure. Side effects of the treatment protocol; Comparison of responses from patients administered by erythropoietin; Impact of the withdrawal of erythropoietin on the quality of life in anemic patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics